MRAs for heart failure update – New developments

Prof Andrew Sindone AM

expert

Prof Andrew Sindone AM

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP

0 hours

These are activities that require reflection on feedback about your work.

MO

0 hours

These are activities that use your work data to ensure quality results.

Description

Mineralocorticoid receptor antagonists (MRAs) are one of the four pillars of heart failure management – but are all MRAs the same? In this talk, cardiologist Professor Andrew Sindone discusses the important role MRAs have in treating heart failure and the differences between the different MRAs available. In particular, he will focus on the MRA, eplerenone and present the evidence that supports the recommendation that it be the first choice when prescribing an MRA to a patient with heart failure with reduced ejection fraction.

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.